EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
122 hedge funds and large institutions have $119M invested in Evofem Biosciences, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 37 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
39% less capital invested
Capital invested by funds: $195M → $119M (-$76.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
122
Holding in Top 10
–
Calls
$1.3M
Puts
$809K
Top Buyers
| 1 | +$8.64M | |
| 2 | +$6.67M | |
| 3 | +$5.43M | |
| 4 |
Millennium Management
New York
|
+$5.03M |
| 5 |
HP
Hound Partners
New York
|
+$2.53M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$1.51M | |
| 3 | -$108K | |
| 4 |
TWMP
Taylor Wealth Management Partners
Boston,
Massachusetts
|
-$86.8K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$61K |